Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY.MX) Q3 2024 Earnings

1AugConfirmed

Q4 2023

Q1 2024

Q2 2024

Q3 2024

-23.15

-5.26

12.63

30.52

Details

Expected EPS

-20.178014611880002

Actual EPS

-2.4583858000000003

Surprise EPS

17.72

Surprise Percent

+87.82%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -2.4583858000000003 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.